Melody Ann Mendenhall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- OtherMasters, 2006
Publications & Presentations
PubMed
- 376 citationsA Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLCAaron Lisberg, Amy L. Cummings, Jonathan W. Goldman, Krikor Bornazyan, Nicholas Dean Reese
Journal of Thoracic Oncology. 2017-11-01 - 32 citationsPD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin - case report.Jonathan W. Goldman, Basmah Abdalla, Melody A. Mendenhall, Anthony Sisk, Jaime Hunt
BMC Nephrology. 2018-08-20 - 24 citationsDiverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features an...John Paul Shen, Jason Chang, Melody A. Mendenhall, Grace Cherry, Jonathan W. Goldman
Therapeutic Advances in Medical Oncology. 2018-01-22
Office
2020 Santa Monica Blvd
Santa Monica, CA 90404Phone+1 310-829-5471Fax+1 310-829-6192
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: